Thrivent Financial for Lutherans Sells 3,039 Shares of HCA Healthcare, Inc. $HCA

Thrivent Financial for Lutherans reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 29.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,151 shares of the company’s stock after selling 3,039 shares during the quarter. Thrivent Financial for Lutherans’ holdings in HCA Healthcare were worth $2,740,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth $1,021,000. T. Rowe Price Investment Management Inc. boosted its position in shares of HCA Healthcare by 13.1% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,546 shares of the company’s stock valued at $880,000 after acquiring an additional 295 shares during the last quarter. CW Advisors LLC increased its position in shares of HCA Healthcare by 22.9% in the first quarter. CW Advisors LLC now owns 1,277 shares of the company’s stock worth $441,000 after purchasing an additional 238 shares during the last quarter. Compound Planning Inc. purchased a new position in HCA Healthcare in the 1st quarter worth approximately $320,000. Finally, Groupe la Francaise purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at $49,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 0.2%

NYSE:HCA opened at $471.94 on Tuesday. The firm has a market capitalization of $107.69 billion, a P/E ratio of 18.24, a P/E/G ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $520.00. The company has a fifty day moving average of $471.35 and a 200 day moving average of $417.92.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HCA. TD Cowen raised their price target on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research report on Monday, October 27th. UBS Group boosted their target price on HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Finally, Sanford C. Bernstein restated a “market perform” rating and set a $417.00 price target on shares of HCA Healthcare in a research report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $479.00.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.